Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT07298395

Public ClinicalTrials.gov record NCT07298395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 1:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ENV-294 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to learn about the safety and effectiveness of ENV-294 in adults with moderate to severe atopic dermatitis. The main questions it will answer are: * Is there an impact on the severity and area of atopic dermatitis when participants take ENV-294 * What medical problems do participants have when taking ENV-294 Participants will: * Take drug ENV-294 or a placebo once every day for 12 weeks * Visit the clinic every 2 to 4 weeks for checkups and tests * Keep a diary of their symptoms and when they took their study drug * Return to the clinic for the final study visit at approximately week 16

Study identification

NCT ID
NCT07298395
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Enveda Therapeutics
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Jul 28, 2026

2025 – 2026

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
Enveda Investigative Site Birmingham Alabama 35244 Recruiting
Enveda Investigative Site Hot Springs Arkansas 71913 Recruiting
Enveda Investigative Site Beverly Hills California 90212 Recruiting
Enveda Investigative Site Fremont California 94538 Recruiting
Enveda Investigative Site San Diego California 92121 Recruiting
Enveda Investigative Site San Diego California 92123 Recruiting
Enveda Investigative Site Santa Monica California 90403 Recruiting
Enveda Investigative Site West Hills California 91307 Recruiting
Enveda Investigative Site Fort Lauderdale Florida 33308 Recruiting
Enveda Investigative Site Miami Florida 33175 Recruiting
Enveda Investigative Site Miramar Florida 33027 Recruiting
Enveda Investigative Site Atlanta Georgia 30327 Recruiting
Enveda Investigative Site Chicago Illinois 60657 Recruiting
Enveda Investigative Site Clarksville Indiana 47129 Recruiting
Enveda Investigative Site New Albany Indiana 47150 Recruiting
Enveda Investigative Site West Lafayette Indiana 47906 Recruiting
Enveda Investigative Site Louisville Kentucky 40217 Recruiting
Enveda Investigative Site Louisville Kentucky 40241 Recruiting
Enveda Investigative Site Auburn Hills Michigan 48326 Recruiting
Enveda Investigative Site Bay City Michigan 48706 Recruiting
Enveda Investigative Site Clinton Township Michigan 48038 Recruiting
Enveda Investigative Site Warren Michigan 48088 Recruiting
Enveda Investigative Site Las Vegas Nevada 89145 Recruiting
Enveda Investigative Site New York New York 10029 Recruiting
Enveda Investigative Site Wilmington North Carolina 28405 Recruiting
Enveda Investigative Site Canton Ohio 44718 Recruiting
Enveda Investigative Site Mayfield Heights Ohio 44124 Recruiting
Enveda Investigative Site Camp Hill Pennsylvania 17011 Recruiting
Enveda Investigative Site Arlington Texas 76011 Recruiting
Enveda Investigative Site Houston Texas 77004 Recruiting
Enveda Investigative Site San Antonio Texas 78218 Recruiting
Enveda Investigative Site Norfolk Virginia 23502 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07298395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2026 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07298395 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →